FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2977367258> ?p ?o ?g. }

• W2977367258 endingPage "e0223164" @default.
• W2977367258 startingPage "e0223164" @default.
• W2977367258 abstract "Pimobendan has gained enormous importance in the treatment of mitral valve disease in dogs. The current consensus statement of the American College of Veterinary Internal Medicine (ACVIM) recommends a treatment for dogs with symptomatic disease and dogs with asymptomatic disease with radiographic and echocardiographic signs of cardiomegaly. To investigate whether these dogs also benefit from a therapy with pimobendan, 21 dogs with mitral valve disease ACVIM B1 underwent a standardized submaximal exercise test on a treadmill. In this double-blinded and randomized study, the animals were divided into two groups, one receiving pimobendan and the other a placebo. At the first visit and at every follow-up appointment (at days 90 and 180), heart rate during the complete exercise test and lactate before and after running were measured. In addition to this, a questionnaire was completed by the dogs’ owners and all dogs were given an echocardiographic examination to detect any changes and to observe if the disease had progressed. Due to the diagnosis of leishmaniosis, one dog in the pimobendan group was retrospectively removed from the study so that 20 dogs were included for statistical analysis. No differences were observed at any time between the pimobendan-group and the placebo-group regarding heart rate. At day 180, the increase in lactate after exercise was significantly lower than in the placebo-group. The increase in the pimobendan-group at day 180 was lower than at day 90. Most of the dog owners from the pimobendan-group declared that their dogs were more active at day 90 (6/10) and at day 180 (8/10), while most dog owners from the placebo-group observed no changes regarding activity at day 90 (8/10) and day 180 (6/10). It can be concluded that the results of this study indicate that some dogs with mitral valve disease ACVIM B1 might benefit from a therapy with pimobendan." @default.
• W2977367258 created "2019-10-10" @default.
• W2977367258 creator A5000866345 @default.
• W2977367258 creator A5011631109 @default.
• W2977367258 creator A5012301349 @default.
• W2977367258 creator A5015008846 @default.
• W2977367258 creator A5016056665 @default.
• W2977367258 creator A5019280027 @default.
• W2977367258 creator A5034786029 @default.
• W2977367258 creator A5071303964 @default.
• W2977367258 creator A5077224202 @default.
• W2977367258 date "2019-10-03" @default.
• W2977367258 modified "2023-09-23" @default.
• W2977367258 title "Effect of pimobendan on physical fitness, lactate and echocardiographic parameters in dogs with preclinical mitral valve disease without cardiomegaly" @default.
• W2977367258 cites W168765785 @default.
• W2977367258 cites W1922851458 @default.
• W2977367258 cites W1973282825 @default.
• W2977367258 cites W1978613001 @default.
• W2977367258 cites W1979076116 @default.
• W2977367258 cites W1992291710 @default.
• W2977367258 cites W2024632319 @default.
• W2977367258 cites W2040513978 @default.
• W2977367258 cites W2043862418 @default.
• W2977367258 cites W2048039545 @default.
• W2977367258 cites W2049814928 @default.
• W2977367258 cites W2080360200 @default.
• W2977367258 cites W2094073584 @default.
• W2977367258 cites W2105558873 @default.
• W2977367258 cites W2117902834 @default.
• W2977367258 cites W2122126886 @default.
• W2977367258 cites W2127951434 @default.
• W2977367258 cites W2141931552 @default.
• W2977367258 cites W2151025586 @default.
• W2977367258 cites W2157459571 @default.
• W2977367258 cites W2161539177 @default.
• W2977367258 cites W2192759937 @default.
• W2977367258 cites W2401964469 @default.
• W2977367258 cites W2525681105 @default.
• W2977367258 cites W2773971449 @default.
• W2977367258 cites W2808265855 @default.
• W2977367258 cites W2939525683 @default.
• W2977367258 cites W2957794604 @default.
• W2977367258 cites W3007585590 @default.
• W2977367258 cites W3014214116 @default.
• W2977367258 cites W4242750497 @default.
• W2977367258 cites W4254610672 @default.
• W2977367258 doi "https://doi.org/10.1371/journal.pone.0223164" @default.
• W2977367258 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6776412" @default.
• W2977367258 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31581204" @default.
• W2977367258 hasPublicationYear "2019" @default.
• W2977367258 type Work @default.
• W2977367258 sameAs 2977367258 @default.
• W2977367258 citedByCount "5" @default.
• W2977367258 countsByYear W29773672582021 @default.
• W2977367258 countsByYear W29773672582022 @default.
• W2977367258 countsByYear W29773672582023 @default.
• W2977367258 crossrefType "journal-article" @default.
• W2977367258 hasAuthorship W2977367258A5000866345 @default.
• W2977367258 hasAuthorship W2977367258A5011631109 @default.
• W2977367258 hasAuthorship W2977367258A5012301349 @default.
• W2977367258 hasAuthorship W2977367258A5015008846 @default.
• W2977367258 hasAuthorship W2977367258A5016056665 @default.
• W2977367258 hasAuthorship W2977367258A5019280027 @default.
• W2977367258 hasAuthorship W2977367258A5034786029 @default.
• W2977367258 hasAuthorship W2977367258A5071303964 @default.
• W2977367258 hasAuthorship W2977367258A5077224202 @default.
• W2977367258 hasBestOaLocation W29773672581 @default.
• W2977367258 hasConcept C126322002 @default.
• W2977367258 hasConcept C142724271 @default.
• W2977367258 hasConcept C164705383 @default.
• W2977367258 hasConcept C1862650 @default.
• W2977367258 hasConcept C204787440 @default.
• W2977367258 hasConcept C27081682 @default.
• W2977367258 hasConcept C2777543888 @default.
• W2977367258 hasConcept C2777910003 @default.
• W2977367258 hasConcept C2777953023 @default.
• W2977367258 hasConcept C2778198053 @default.
• W2977367258 hasConcept C2779134260 @default.
• W2977367258 hasConcept C2781464450 @default.
• W2977367258 hasConcept C71924100 @default.
• W2977367258 hasConcept C84393581 @default.
• W2977367258 hasConceptScore W2977367258C126322002 @default.
• W2977367258 hasConceptScore W2977367258C142724271 @default.
• W2977367258 hasConceptScore W2977367258C164705383 @default.
• W2977367258 hasConceptScore W2977367258C1862650 @default.
• W2977367258 hasConceptScore W2977367258C204787440 @default.
• W2977367258 hasConceptScore W2977367258C27081682 @default.
• W2977367258 hasConceptScore W2977367258C2777543888 @default.
• W2977367258 hasConceptScore W2977367258C2777910003 @default.
• W2977367258 hasConceptScore W2977367258C2777953023 @default.
• W2977367258 hasConceptScore W2977367258C2778198053 @default.
• W2977367258 hasConceptScore W2977367258C2779134260 @default.
• W2977367258 hasConceptScore W2977367258C2781464450 @default.
• W2977367258 hasConceptScore W2977367258C71924100 @default.
• W2977367258 hasConceptScore W2977367258C84393581 @default.
• W2977367258 hasIssue "10" @default.
• W2977367258 hasLocation W29773672581 @default.
• W2977367258 hasLocation W29773672582 @default.

• next